Kingsview Wealth Management LLC grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 2.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 4,354 shares of the medical equipment provider’s stock after acquiring an additional 94 shares during the period. Kingsview Wealth Management LLC’s holdings in Intuitive Surgical were worth $2,273,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also recently modified their holdings of ISRG. TFG Advisers LLC increased its stake in Intuitive Surgical by 9.0% during the 4th quarter. TFG Advisers LLC now owns 821 shares of the medical equipment provider’s stock worth $429,000 after buying an additional 68 shares during the period. Vest Financial LLC increased its position in shares of Intuitive Surgical by 22.1% during the fourth quarter. Vest Financial LLC now owns 2,725 shares of the medical equipment provider’s stock worth $1,422,000 after acquiring an additional 493 shares during the period. Conning Inc. raised its stake in shares of Intuitive Surgical by 7.4% in the fourth quarter. Conning Inc. now owns 3,629 shares of the medical equipment provider’s stock valued at $1,894,000 after acquiring an additional 249 shares in the last quarter. Realta Investment Advisors boosted its holdings in Intuitive Surgical by 3.8% in the fourth quarter. Realta Investment Advisors now owns 2,200 shares of the medical equipment provider’s stock valued at $1,178,000 after purchasing an additional 81 shares during the period. Finally, Triasima Portfolio Management inc. acquired a new position in Intuitive Surgical during the 4th quarter worth $266,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.
Analyst Ratings Changes
A number of equities research analysts have issued reports on ISRG shares. CICC Research initiated coverage on Intuitive Surgical in a research report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target on the stock. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. Evercore ISI lifted their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Finally, Jefferies Financial Group increased their target price on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $613.10.
Intuitive Surgical Stock Performance
Shares of NASDAQ:ISRG opened at $595.70 on Tuesday. The stock has a market capitalization of $212.18 billion, a price-to-earnings ratio of 92.93, a PEG ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The company has a 50-day simple moving average of $554.85 and a 200-day simple moving average of $514.80.
Insiders Place Their Bets
In related news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Jamie Samath sold 269 shares of the company’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the transaction, the chief financial officer now owns 3,282 shares in the company, valued at $1,936,380. The trade was a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 5,940 shares of company stock worth $3,346,964. Company insiders own 0.90% of the company’s stock.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Merck: 4 No-Brainer Reasons to Buy This Dip
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- How to Evaluate a Stock Before Buying
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.